Transcode Therapeutics, INC. (RNAZ) — 8-K/A Filings

All 8-K/A filings from Transcode Therapeutics, INC.. Browse 4 Amended Current Event Report reports with AI-powered summaries and risk analysis.

8-K/A Filings (4)

Transcode Therapeutics Files 8-K Amendment — Dec 23, 2025 Risk: low
Transcode Therapeutics, Inc. filed an amendment (No. 3) to its Form 8-K on December 23, 2025, reporting events that occurred on October 8, 2025. The filing prim
Transcode Therapeutics Files 8-K/A Amendment — Oct 17, 2025 Risk: low
Transcode Therapeutics, Inc. filed an amendment (8-K/A) on October 17, 2025, to a previous report concerning a material definitive agreement. The original event
Transcode Therapeutics Files 8-K Amendment — Oct 8, 2025 Risk: low
Transcode Therapeutics, Inc. filed an amendment (Amendment No. 1) to its Form 8-K on October 8, 2025. This amendment pertains to the entry into a material defin
TransCode Therapeutics Corrects Shareholder Meeting Vote Results — Jun 14, 2024 Risk: low
TransCode Therapeutics, Inc. filed an amendment (8-K/A) on June 14, 2024, to its June 13, 2024, 8-K filing. This amendment corrects an error stating that not al

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX